Lipsome containing IL-2
US5773006A · kind A · utility
9Cited by
32References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 1995 |
| Grant date | Jun 30, 1998 |
| Priority date | — |
| Expiry date | Apr 7, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a liposome comprising an effective immunoadjuvant amount of a lymphokine such as IL-2. Also provided is an effective antineoplastic amount of IL-2 liposomes in combination with adoptively transferred cells stimulated with anti-CD3 monoclonal antibody plus IL-2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.